![[Video] The Weekly Break Out Ep. 19: Army aviation’s shakeup and the F-35’s future](https://breakingdefense.com/wp-content/uploads/sites/3/2025/05/EP-19-THUMB-play-button.jpg?#)
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build next-gen central nervous system drugs.
Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build next-gen central nervous system drugs.
